Overview

Pain Study in Total Knee Arthroplasty

Status:
Completed

Trial end date:
2019-05-31

Target enrollment:

Participant gender:

Summary

This is a Phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 vs. placebo injected/instilled during an elective TKA.

Phase:

Phase 2

Details

Lead Sponsor:

Concentric Analgesics